Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine [Phase 4]
Phase 4 clinical trial update evaluating melancholic symptoms in bipolar depression and the responsiveness of patients to lamotrigine. Resul…
-
CLINICAL_TRIALS trial_result · 2019-02-07Clinical Trial Update: Efficacy of an Innovative E-neurocognitive Module for Bipolar Disorder [NA]
Completed clinical trial evaluating the efficacy of an e-neurocognitive module for bipolar disorder.
-
CLINICAL_TRIALS research · 2019-02-06Clinical Trial Update: Understanding Treatment Adherence Among Individuals With Rapid Cycling Bipolar Disorder
A completed clinical trial update from Case Western Reserve University examining treatment adherence among individuals with rapid cycling bi…
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder [Phase 3]
Phase 3 clinical trial assessing fixed-dose cariprazine versus placebo for depressive episodes in Bipolar I Disorder has completed with resu…
-
CLINICAL_TRIALS research · 2019-02-01Clinical Trial Update: Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder [NA]
This update notes a completed clinical trial examining microbiome-targeted strategies for improving outcomes in bipolar disorder.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Person-Centered Versus Measurement-Based Care in Mental Health [NA]
Completed clinical trial comparing person-centered care to measurement-based care in mental health; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression [Phase 3]
This Phase 3 clinical trial update reports results comparing cariprazine to placebo in Bipolar I Depression, assessing efficacy, safety, and…
-
FDA label_change · 2019-01-25FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA supplemental application for Risperdal M-TAB (risperidone) by Janssen Pharmaceuticals, involving changes to the product label. This acti…
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain [Phase 2]
Phase 2 trial evaluating betahistine for efficacy and tolerability in reducing antipsychotic-associated weight gain; the study is completed …
-
FDA approval · 2019-01-25FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal Consta (risperidone) from Janssen Pharmaceuticals, Inc., indicating a supplemental app…
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Family Focused Therapy for Teens at Risk for Bipolar Disorder [NA]
A terminated clinical trial update concerns Family Focused Therapy for adolescents at risk for bipolar disorder.
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Adjunctive Psychotherapy for Perinatal Bipolar Disorder [NA]
A Brown University-sponsored clinical trial evaluating adjunctive psychotherapy for perinatal bipolar disorder was terminated.
-
CLINICAL_TRIALS trial_result · 2019-01-09Clinical Trial Update: Treatment of Alcohol Dependence and Comorbid Bipolar Disorder [Phase 4]
Phase 4 clinical trial updating treatment for alcohol dependence with comorbid bipolar disorder; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2019-01-07Clinical Trial Update: Probiotics to Prevent Relapse After Hospitalization for Mania [NA]
Clinical trial investigating probiotics to prevent relapse after hospitalization for mania in bipolar and schizoaffective disorders has comp…
-
FDA approval · 2019-01-04FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's generic lurasidone hydrochloride (an Abbreviated New Drug Application) for the treatment of schizophre…
-
FDA approval · 2019-01-03FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare's generic lurasidone hydrochloride via an Original Application (ANDA). The generic is indicated for schizophr…
-
FDA approval · 2019-01-03FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic lurasidone hydrochloride under an Original ANDA, expanding access to this antipsychotic as a gen…
-
FDA approval · 2019-01-03FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Exelan Pharmaceuticals Inc.)
FDA approved Exelan Pharmaceuticals Inc.'s original application for lurasidone hydrochloride (generic lurasidone) capsules.
-
FDA approval · 2019-01-03FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal's generic LURASIDONE HYDROCHLORIDE (ANDA) for the same indications as the brand Latuda. These indications include schizo…
-
FDA approval · 2019-01-03FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's Original Application for Lurasidone Hydrochloride (generic lurasidone) for marketing in the U…
-
FDA approval · 2018-12-20FDA Approved: LITHIUM CARBONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for lithium carbonate submitted by Hikma Pharmaceuticals USA Inc.
-
FDA label_change · 2018-12-20FDA Approved: LITHIUM CARBONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Lithium carbonate submitted by Hikma Pharmaceuticals USA Inc., resulting in changes to the produ…
-
FDA approval · 2018-12-20FDA Approved: LITHIUM CARBONATE ER — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Lithium carbonate ER submitted by Glenmark Pharmaceuticals Inc., USA, representing an approved c…
-
FDA approval · 2018-12-20FDA Approved: LITHIUM CARBONATE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for lithium carbonate filed by Rising Pharma Holdings, Inc., indicating an approved modification…
-
FDA approval · 2018-12-20FDA Approved: LITHOBID — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lithobid (lithium carbonate) from ANI Pharmaceuticals, Inc.